×
A 9-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder in a Population Sample PDF
$ 40.00
A 9-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder in a Population Sample PDF quantity
$ 40.00
×
Benzodiazepines Prescribed With and Without Opioids: A Cross-Sectional Study of Data From the National Ambulatory Medical Care Survey 2018–2019 PDF
$ 40.00
Benzodiazepines Prescribed With and Without Opioids: A Cross-Sectional Study of Data From the National Ambulatory Medical Care Survey 2018–2019 PDF quantity
$ 40.00
×
Loss of Erection Followed by Spontaneous Ejaculation: A COVID-19 Phenomenon? PDF
$ 40.00
Loss of Erection Followed by Spontaneous Ejaculation: A COVID-19 Phenomenon? PDF quantity
$ 40.00
×
Efficacy and Safety of Loxapine in Acute Agitation: A Systematic Review of Interventional Studies PDF
$ 40.00
Efficacy and Safety of Loxapine in Acute Agitation: A Systematic Review of Interventional Studies PDF quantity
$ 40.00
×
Mental Health From the Perspective of Primary Care Residents: A Pilot Survey PDF
$ 40.00
Mental Health From the Perspective of Primary Care Residents: A Pilot Survey PDF quantity
$ 40.00
×
The Problem of the Doctor as Patient PDF
$ 40.00
The Problem of the Doctor as Patient PDF quantity
$ 40.00
×
Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report PDF
$ 40.00
Sudden Reduction in Caffeine Intake Increases Serum Lithium Concentration to Supratherapeutic Level: A Case Report PDF quantity
$ 40.00
×
Mother-Infant Antidepressant Concentrations, Maternal Depression, and Perinatal Events PDF
$ 40.00
Mother-Infant Antidepressant Concentrations, Maternal Depression, and Perinatal Events PDF quantity
$ 40.00
×
Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years PDF
$ 40.00
Dosing Quetiapine in Drug-Naive First-Episode Psychosis: A Controlled, Double-Blind, Randomized, Single-Center Study Investigating Efficacy, Tolerability, and Safety of 200 mg/day vs. 400 mg/day of Quetiapine Fumarate in 141 Patients Aged 15 to 25 Years PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart